Synthetic swine epidermal growth factor (rEGF) is receiving increased recognition as a valuable strategy in the field of regenerative therapy. This biological agent, manufactured through molecular technology, offers a https://recombinant-porcine-egf343680.octoberblog.com/61597228/engineered-swine-cutaneous-development-protein-a-effective-agent-for-tissue-repair